This piece investigates the drug Flibanserin, a drug designed to increase women’s sexual desire by interacting with the brain. The drug, however, has become rather political.
“‘We live in a culture that has historically discounted the importance of sexual pleasure and sexual desire for women,’ says Terry O’Neill, president of the National Organization for Women. ‘And I fear that it’s that cultural attitude that men’s sexual health is extremely important, but women’s sexual health is not so important. That’s the cultural attitude that I want to be sure the FDA has not, maybe unconsciously, imported into its deliberative process.'”